Impact of interferon-free regimens in patients with chronic HCV and successfully ablated HCC
Abstract Background Hepatocellular carcinoma (HCC) ranks sixth amongst all cancers and is the 2nd top cause of mortality attributable to cancer. Aim of the work This study aimed to ascertain the sustained virological response (SVR) to interferon-free regimens in chronic people with HCV after the suc...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SpringerOpen
2025-02-01
|
| Cyfres: | Egyptian Liver Journal |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1186/s43066-025-00406-2 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
